Racial discrimination has been a lightning rod for passionate discourse and social action in the US for decades, if not centuries. The recent killings of African Americans by law enforcement has amplified the discourse. Health care has not been immune to such tragedies, with past experimentation without informed consent and segregation in health care facilities. These were systemically ingrained, institutional practices without ethical or evidentiary footing. Race was an identifying characteristic used to implement practices that resulted in consequences for health and well-being. The use of race in algorithms for clinical care, including for kidney disease, has generated and now even more so is generating discourse and action about current-day, systemic discrimination in health care.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Powe NR. Black Kidney Function Matters: Use or Misuse of Race? JAMA. 2020;324(8):737–738. doi:10.1001/jama.2020.13378
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.